Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...